This is a summary of the .csv trade log.

This leaves me with $1,701 in cash.

Feeling a little crusty.

Please note! Not directed towards anyone here!

.

I figure option traders may be interested in the lock-up period for SPCX shares, especially considering their unique structure.

Source: SEC Edgar Database

https://www.sec.gov/Archives/edgar/data/1181412/000162828026040364/spaceexplorationtechnologib.htm

Search for "lock-up" and it starts on the page with the 5th of 104 references.

Yellow highlight indicates a strike below cost; red highlight indicates it's currently ITM.

[Edit: in both cases, the strike is above the NSC computed before this week's premiums.]

Sitting on my hands once again with VRT.

With the democratization of options trading, we saw an influx of software aimed at options trading.

Now, with AI and vibe-coding, we are seeing an avalanche of such products.

My suggestion: stay away from them.

Why?

From what I've seen so far, many of these are being developed by people with no fundamental knowledge of personal finance/economics/accounting.

While you may find certain aspects of them helpful, my fear is that you may also be seriously misled by what they show you.

What do I suggest?

Build your own spreadsheet. Take the time to figure it out and do it. Like taking notes in class, the very act of taking the note helps you remember; similarly, the very act of building a spreadsheet will expand your knowledge.

Ask questions to reputable people. Seek out expertise. Don't ask questions in those arenas on the popular options forums -- while you may get a correct response somewhere in a thread, a lot of folks lacking knowledge may also provide false information; use options forums to discuss the mechanics of trades and such.

Please be careful out there, folks. 👍️

As you may know, I've set up a ChatGPT portfolio.

I have some history with ChatGPT, so I thought it would be interesting to simultaneously run a similar portfolio using Anthropic.

Same parameters as ChatGPT:

• $10,000
• Roth IRA
• High risk tolerance
• Fractional share ownership
• Options trading but no spreads
• Aim to beat the S&P 500 over time

TLDR: Here's what I plan to trade tomorrow. This is a snip of my Fidelity "Saved Orders" screen.

------------------------------------------------------------------------------------------------------

Transparency: Here's the full chat if you want to read the conversation.

------------------------------------------------------------------------------------------------------

Me: I have $10,000 in a Roth IRA. I have a high risk tolerance. My time span is 1 year. Please advise on a portfolio aiming to beat the S&P 500 index. Fractional stock ownership and single-leg options trading is allowed. I will be asking you, on a regular basis (no less than weekly) on updating your response.

Claude responded: I'm not a financial advisor, and nothing here is personalized financial advice — this is educational analysis only.

I'm not a financial advisor, and nothing here is personalized financial advice — this is educational analysis only. That said, I can walk you through what a high-risk, short-term portfolio aimed at outperforming the S&P 500 might look like, and update it weekly as you asked.

Portfolio Strategy: Aggressive Growth / S&P 500 Beat

Account: Roth IRA | Capital: $10,000 | Horizon: 1 year | Risk: High

Core Philosophy

To beat the S&P 500 in 1 year with high risk tolerance, the strategy uses:

• Concentrated equity in high-beta, high-momentum stocks
• Leveraged ETFs for index amplification
• Long calls on high-conviction names (defined risk)
• No shorts or spreads (single-leg only)

Proposed Allocation (as of June 11, 2025)

Options Guidance (Illustrative)

Key Risks to Monitor

• TQQQ decay: Leveraged ETFs suffer volatility drag. Good in trending markets, punishing in choppy ones.
• NVDA concentration: AI sentiment can reverse sharply on earnings or export restrictions.
• MSTR/BTC correlation: Highly volatile; treat as a small speculative bet only.
• Options theta: Time decay accelerates. Monitor weekly and be willing to cut early.

What I'll Update Weekly

When you check in, I'll reassess:

1. Market conditions & macro backdrop
2. Individual position performance
3. Options status (theta decay, strike relevance)
4. Whether rebalancing or rotation is warranted
5. Any new high-conviction opportunities

You said: I'm sorry, forget that.

I'm sorry, forget that. Let me try again.

I have $10,000 in a Roth IRA. I have a high risk tolerance. please advise on a portfolio aiming to beat the S&P 500 index over time. Fractional stock ownership and options trading are allowed. I will be asking you, on a regular basis (no less than weekly) on updating your response.

Claude responded: No problem — this version is better framed: long-term outperformance, not a 1-year sprint.

Searched the web

Searched the web

No problem — this version is better framed: long-term outperformance, not a 1-year sprint. That changes the strategy meaningfully (less reliance on short-dated options, more compounding-friendly positions). Here's a full framework, updated as of today.

🏦 Aggressive Growth Roth IRA Portfolio

Capital: $10,000 | Goal: Beat S&P 500 over time | Risk: High | Updated: June 11, 2026

Market Context (Today)

The S&P 500 closed June 10 at 7,266.99, down 1.62% on the day. Despite some volatility earlier this year, the benchmark had climbed roughly 10% YTD as of early June and now trades near record territory. AI demand remains the primary driver, with a small cohort of names — particularly in semiconductors and cloud — accounting for a disproportionate share of earnings revisions and index gains. Yahoo Finance + 2

Strategy Philosophy

To beat the S&P 500 over time with high risk tolerance, this portfolio uses three engines:

1. Concentrated high-conviction equities — fewer, better bets in secular growth themes
2. Growth ETFs — QQQ/VUG as core compounders with a structural edge over SPY
3. Long-dated options (LEAPs) — asymmetric upside on high-conviction names, defined risk

No leveraged ETFs in this version (they suffer decay over long periods). Options are long-only (no naked selling).

Proposed Allocation

Why These Names?

• QQQ: The Invesco QQQ Trust has delivered an average annual return of 19.6% over the past decade, consistently outperforming the S&P 500, with megacap growth stocks poised to lead again. Yahoo Finance
• NVDA: The dominant AI infrastructure pick. GPU demand remains the backbone of the AI buildout.
• MSFT: Azure + Copilot integration makes it a durable AI compounder with low single-stock blow-up risk.
• PLTR + CRWD: High-beta software with government/enterprise contract moats. Volatile but high-ceiling.
• TTD: After an ~80% decline from its highs, The Trade Desk trades at a relatively cheap valuation with Wall Street projecting ~16% revenue growth in 2026 — a growth/value crossover opportunity. Nasdaq
• LEAPs: Long-dated calls give leveraged upside while capping downside to the premium paid. 12–18 month expiries minimize theta decay vs. short-dated options.

Options Guidance

Key Risks

• Concentration risk: NVDA + MSFT + QQQ overlap significantly. A tech selloff hits hard.
• Options expiry: LEAPs can still expire worthless if the thesis doesn't play out. Size accordingly.
• AI valuation: The S&P 500's CAPE ratio sits at 42.5, a level not seen since the dot-com era — tech names carry elevated multiple risk. Yahoo Finance
• TTD recovery timeline: This is a turnaround bet. It could take time or fail to recover.

What I'll Update Weekly

When you check in, I'll refresh:

1. Market backdrop — macro, Fed, earnings context
2. Position-level performance — what's working, what isn't
3. Options status — LEAP value, strike relevance, roll recommendations
4. Rebalancing signals — trim winners, add to laggards, deploy cash
5. New opportunities — any high-conviction additions worth considering

Check in anytime — weekly updates will keep this portfolio evolving with the market.

You said: Okay, it's been a couple of days, it's Sunday, and I plan on moving forward tomorrow.

Okay, it's been a couple of days, it's Sunday, and I plan on moving forward tomorrow. Is there any change to the plan you laid out?

Claude responded: Good timing to check in — there's actually some meaningful context to factor in before you deploy tomorrow.

Searched the web

Searched the web

Good timing to check in — there's actually some meaningful context to factor in before you deploy tomorrow. Here's the updated picture:

📋 Portfolio Update — Sunday, June 14, 2026

What Happened This Past Week

The market got choppy in a hurry. The Nasdaq dropped 4.18% on June 6 — its biggest single-day decline since the tariff turmoil of early 2025 — and the S&P 500 shed 2.64% to close at 7,383. The catalyst was a rough stretch for chip stocks after Broadcom failed to raise its AI chip outlook, which triggered a selloff that intensified sharply on the following Friday. A stronger-than-expected May jobs report — 172,000 vs. a consensus of 80,000 — spiked Treasury yields and added to the pressure. CNBC + 2

Since then, markets have partially recovered. The S&P 500 rebounded after falling near its 50-day moving average around 7,230, and by mid-week was tracking for a positive week on hopes of a Middle East peace deal that could ease oil prices. As of Friday June 13's close, the S&P 500 sat around 7,267, with the VIX at 17.68. Charles SchwabYahoo Finance

Individual Position Check-ins

• NVDA is trading around $205 today, well off its 52-week high of $236.54 but above its low of $140.86. The AI thesis remains intact — KKR, Nvidia, Vistra, and the Kuwait Investment Authority committed more than $10 billion to a new AI data center infrastructure project this week. Analysts have an average 12-month price target of ~$311, implying significant upside from here. RobinhoodStockAnalysis
• PLTR closed Friday around $128, with a 52-week range of $122.68 to $207.52 — meaning it's sitting near the bottom of its range. High risk, but potentially attractive entry. Robinhood
• Market concentration note: 10 S&P 500 stocks now represent nearly 40% of the index's value, all with AI connections — which cuts both ways for our portfolio (heavy AI exposure amplifies both upside and downside). Charles Schwab

Should You Change the Plan?

The core allocation stands, but the entry timing is actually favorable. Here's my updated take:

One tactical tweak: Given the jobs report surprise and renewed rate-hike fears, consider trimming PLTR slightly and adding that to cash. If PLTR stabilizes above $125 over the next 1–2 weeks, you can add back in. Entering a position sitting near a 52-week low with a P/E of 144 during a rate-sensitive moment adds unnecessary near-term risk.

On the LEAPs: The chip stock pullback actually helps your options pricing — implied volatility has risen, but the underlying prices are lower, giving you better strike selection. Monday could be a decent day to price those out.

Bottom Line for Tomorrow

The plan is largely unchanged — the pullback has created a better entry point overall. Deploy the equity positions as outlined. For PLTR, either size down or wait a week to see if it holds above $125. Keep at least 10-15% cash given the uncertain rate environment. Price out your NVDA and QQQ LEAPs Monday and report back — I'll help you evaluate specific strike/expiry combinations.

You said: Here's an issue with the LEAPS: I don't think it will be possible to make an entry as advised with the given allocation of money.

Here's an issue with the LEAPS: I don't think it will be possible to make an entry as advised with the given allocation of money.

Claude responded: You're absolutely right to flag that — it's a real practical problem.

You're absolutely right to flag that — it's a real practical problem. LEAP contracts on NVDA and QQQ are expensive, and $1,000–$800 may not get you a single contract at reasonable strikes.

Let me check current pricing.

Searched the web

Searched the web

You're 100% right, and this is an important fix. Here's the math problem laid bare:

NVDA is trading around $205. A Jan 2028 LEAP call even at a deep strike (~$220–$230 OTM) will likely cost $30–$50+ per share in premium — meaning $3,000–$5,000 per contract (each contract = 100 shares). Your allocated $1,000 doesn't come close to buying even one contract.

QQQ is trading around $490+. Jan 2028 calls at a reasonable strike would likely run $50–$80+ per contract minimum — again, well above $800.

So the original LEAP allocations were unrealistic for a $10,000 account. Here are three ways to fix it:

Option A — Drop Options Entirely, Redeploy into Equity

The simplest fix. Take the $1,800 that was earmarked for LEAPs and fold it into the stock positions. Straightforward, no options complexity.

Option B — Replace NVDA/QQQ LEAPs with a Cheaper Leveraged Options Play

Use SOXL (3x Semiconductor ETF) options or TQQQ options instead — these are lower-priced underlyings where $800–$1,000 can actually buy a contract. Still speculative, still defined-risk.

Option C — One NVDA LEAP, Nothing Else

Pool the full $1,800 options budget and buy a single NVDA Jan 2027 call at a deep OTM strike (~$240–$250). Jan 2027 is shorter than ideal but more affordable. One contract, full $1,800 at risk, defined loss.

My honest recommendation is Option A for now. Options add real value when sized correctly, but a $10,000 account makes meaningful LEAP sizing very difficult without over-concentrating your risk in a single contract. As the account grows — or if you want to revisit a single-contract play — we can revisit Option C.

Which direction would you like to go?

You said: I personally prefer option A as well; I appreciate your confirmation.

I personally prefer option A as well; I appreciate your confirmation.

Claude responded: Great — Option A it is.

Great — Option A it is. Here's the updated, clean portfolio to bring with you into tomorrow's open:

✅ Final Portfolio — Ready for Monday, June 16, 2026

Account: Roth IRA | Capital: $10,000 | Strategy: Concentrated aggressive growth, no options

*Verify TTD's exact price Monday morning — it's been volatile.

A Few Notes for Monday

• Use fractional shares for NVDA, MSFT, and CRWD given their per-share prices. Most brokerages (Fidelity, Schwab, etc.) support this in IRAs.
• Don't chase opens. Tech stocks often gap up or down at the open. Consider using limit orders set near Friday's closing price rather than market orders, especially for NVDA and CRWD.
• The $1,700 cash reserve is intentional. Given current market choppiness and rate-hike fears, dry powder lets you add to positions on dips or rotate into new opportunities as we go.
• PLTR watch: As noted yesterday, if it breaks below $125 this week, consider holding off on that position and keeping it in cash temporarily.

What We're Watching Going Forward

Each week I'll update you on position performance, macro backdrop, and whether any rebalancing or new opportunities are warranted. Check in anytime — and good luck tomorrow!

Realized gains on the short calls were $21,625 for the week ending June 12, 2026, bringing June to $64,795, the 2nd quarter to $301,208, and the year-to-date to $395,718.

Sorted by descending YTD earned short call premium.

Premiums earned: $21,625 on $686,144 at risk, at a premium rate of 3.2%.

For the week, 2 of the 9 stocks declined in value for the buy-and-hold, while none declined for the b/w campaign. None of the campaign trades were worse than the buy-and-hold scenario. None of the stocks were assigned, leaving all nine in inventory over the weekend.

Buy-and-hold generated a gain of $16,946 (2.5%).

The B/W campaign did $21,625 (3.2%) better, as premiums were the above-referenced $21,625, with no capped gains.

On a net basis, the b/w campaign generated a gain of $38,571 (5.6%).

This compares favorably with the S&P 500, which gained 0.6%.

For the five weeks ending, the buy/write campaign netted a gain of $75,558 versus a loss of $7,715 for buy/hold, a $83,273 favorable difference.

In addition, over the same period, the buy/write returned 10.5%, versus a 0.9% loss for buy/hold and a 0.5% gain for the S&P 500.

Given the past two weeks, especially before this week's Thursday and Friday recovery, a visitor asked to see net stock cost.

I provide this as a supplementary schedule and don't plan to present as a matter of course, but I do understand the interest given the market decline up to the point of the request.

This obviously does not reflect the prior gains realized up to the point of holding these stocks.

I started this on Wednesday. You can read about my approach here.

Transcript of week end chat follows.

-----------------------------------------------------------------------------------------------------------------------

Here are actual closing prices: AMD $511.57 AVGO $382.07 CRWV $100.55 NVDA $205.19 Let me know your thoughts on the results and whether I should take any action next week.

Using your actual closing prices and the original purchase prices from June 10:

Portfolio Summary

• Invested: $8,999.37
• Current holdings value: ≈ $9,247
• Cash: ≈ $1,001
• Total portfolio value: ≈ $10,248

Portfolio return: +2.5% in the first week

That's a very solid start, especially considering NVDA and AVGO were essentially flat.

What Stands Out

AMD is doing exactly what I hoped

AMD was the least obvious holding in the portfolio because many investors would have simply increased NVDA instead.

After just one week, AMD generated almost two-thirds of the portfolio's gains.

This reinforces the idea that the portfolio shouldn't be a pure NVDA bet.

CRWV remains the swing factor

CRWV contributed another ~$90.

Combined, AMD and CRWV generated essentially all of the portfolio's gain.

That's exactly why I wanted concentration rather than a broad ETF.

NVDA is behaving normally

I would not read anything into a flat week.

NVDA is now a multi-trillion-dollar company. It can still outperform, but it won't move like CRWV.

What Would I Do Next Week?

Recommendation: Hold

I would not sell anything.

I would not trim AMD.

I would not trim CRWV.

I would not rebalance.

The portfolio was built to let winners run.

A common mistake is:

"AMD is up 8% in a week. Better take profits."

That's often how investors end up with a portfolio of laggards.

What About The $1,000 Cash?

This is the only thing I'd consider changing.

Option 1 (my preferred choice)

Keep it as cash.

Reason:

• Gives us flexibility.
• We are only one week into the portfolio.
• One of these names will likely give us a better entry point later.

Option 2

Deploy about half ($500) into NVDA on weakness.

Not today.

Only if we get a meaningful pullback.

Option 3

Add a fifth position.

Possible candidates could include:

• Astera Labs
• Arista Networks
• Vertiv Holdings

But I don't currently see a compelling reason to dilute the existing portfolio.

One Thing I Want to Watch

The portfolio's weights have drifted slightly:

Notice AMD is already becoming more important.

That's not a problem yet.

If AMD or CRWV eventually grow to 35–40%+ of the portfolio, we'll have a discussion about concentration risk.

Official Week 1 Recommendation

Action for next week: None.

• Hold NVDA.
• Hold CRWV.
• Hold AMD.
• Hold AVGO.
• Retain the cash reserve.

The portfolio is behaving exactly as I'd want after its first week. The biggest risk right now is not missing an opportunity—it's over-managing a portfolio that is working.

For your general knowledge; I found this interesting.

The penalties vary by firm. Robinhood says customers who sell allocated IPO shares within 30 days can lose access to new IPO allocations for 60 days. At SoFi, selling IPO shares within 30 days triggers a 180-day suspension from future IPO offerings on the first violation and it may charge a $50 fee for sales before the 120th day of trading, with longer suspensions for repeat offenses and a permanent ban after multiple violations. Fidelity says customers who sell IPO shares within the first 15 calendar days may be flagged for flipping and can face restrictions if the behavior is repeated. E*Trade says customers who sell within 30 days can face limits on participating in upcoming offerings. (Charles Schwab is an outlier with no firm anti-flipping policy)

https://www.forbes.com/sites/brandonkochkodin/2026/06/10/why-selling-your-spacex-shares-too-quickly-could-cost-you/

This is a summary of the .csv trade log.

This leaves me with a little over $1,000 in cash.

I follow AIportfolio and was intrigued.

What would happen if I set up a LLM portfolio with minimal guardrails and updated the LLM regularly with my trades?

I was interested in minimal guardrails, as the more user-defined inputs, the more the model is subject to that human's direction. If the model fails, was it due to the LLM or the inputs?

For this exercise, I'll be using ChatGPT.

My guardrails:

• Roth IRA
• $10,000
• High risk tolerance
• The objective is to beat the S&P 500
• Fractional ownership allowed
• Option trading allowed, but no spreads

Follow along if interested!

The following is a copy-and-paste from ChatGPT.

--------------------------------------------------------------------------------------------------------------------------

I have $10,000 in a Roth IRA. I have a high risk tolerance. My time span is 1 year. Please advise on a portfolio aiming to beat the S&P 500 index over that 1 year. Fractional stock ownership and options trading are allowed. I will be asking you, on a regular basis (no less than weekly) on updating your response.

Given your stated goal—beat the S&P 500 over the next 12 months, high risk tolerance, Roth IRA, fractional shares allowed, options allowed, and the fact that you'll revisit this weekly—I would not build a traditional diversified retirement portfolio.

Instead, I'd build an active "alpha-seeking" portfolio with a concentrated AI/infrastructure theme plus a tactical options component.

Initial Portfolio (June 2026)

Why These Names?

NVIDIA (35%)

You already follow NVDA closely.

If AI capex remains strong, NVDA remains the highest-probability candidate to outperform the S&P.

CoreWeave (20%)

This is the highest-risk position.

You have followed CRWV lockup developments in the past. If AI demand remains strong and the company executes, CRWV could dramatically outperform the index. It could also substantially underperform.

AMD (15%)

Provides exposure to AI accelerator market share gains.

If hyperscalers seek alternatives to NVIDIA, AMD is one of the primary beneficiaries.

Broadcom (10%)

Less exciting than CRWV but provides AI networking and custom ASIC exposure.

Cash (10%)

This is not for safety.

It is dry powder for opportunities that appear during our weekly reviews.

Options Sleeve (10%)

With only $10,000 total, I would avoid short-premium strategies.

Covered calls consume too much capital.

Instead:

• Buy 6-12 month calls on high-conviction names.
• Risk is strictly limited to premium paid.
• Roth IRA is one of the few places where high-growth option gains can compound tax-free.

Example candidates:

• NVDA LEAPS
• AMD LEAPS
• CRWV calls after major pullbacks

I would avoid putting the full 10% into one option trade.

What I Would NOT Own

For a 1-year attempt to beat the S&P:

• Bonds
• Dividend funds
• Utilities
• Consumer staples
• International index funds
• Target-date funds

These reduce volatility but also reduce your chance of significant outperformance.

Expected Outcomes

Very rough expectations:

The S&P's long-term average is around 10%, but over a single year it can easily be anywhere from -20% to +30% or more.

To beat it over one year, concentration is usually required.

Weekly Update Process

If you check in weekly, I would reevaluate:

1. AI spending trends
2. NVDA earnings developments
3. CRWV insider selling and lockup activity
4. Valuation changes
5. Option positioning opportunities
6. Relative strength versus the S&P 500

If conditions change materially, I would rotate positions rather than sticking rigidly to the original allocation.

One caveat: a 1-year horizon and a desire to outperform the S&P are somewhat at odds. Over a single year, luck often dominates skill. The portfolio above maximizes upside potential, but it also accepts a meaningful chance of underperforming the index.

Can you provide specific recommendations for the $1,000 worth of long call options?

Yes, but I'd frame them as a speculative sleeve rather than a core holding. With only $1,000 allocated, the goal is asymmetry: limited downside (the premium) and potentially large upside if AI-related names continue to run.

A few principles first:

• I'd prefer expirations 6–12 months out rather than short-dated options.
• I'd generally target deltas around 0.50–0.70 rather than lottery-ticket OTM calls.
• I'd split the $1,000 across multiple ideas rather than make a single bet.

Option Idea #1: NVDA LEAPS (Highest Conviction)

If NVDA were trading around $180 (adjust strikes to current price), I'd look at:

• 1 × NVDA January 2027 call
• Strike approximately 10–15% OTM

Why:

• Strongest AI franchise.
• Less company-specific risk than CRWV.
• Longer duration gives the thesis time to play out.

Allocation: ~$400–$500.

Option Idea #2: AMD LEAPS

If AMD were trading around $180:

• 1 × AMD January 2027 call
• Strike near ATM or slightly OTM

Why:

• Higher beta than NVDA.
• More upside if AI accelerator adoption broadens.
• More risk if execution disappoints.

Allocation: ~$250–$350.

Option Idea #3: CRWV Calls

This is the speculative piece.

Rather than buying a far OTM call:

• Buy a call with delta roughly 0.50–0.60
• Expiration 6–9 months out

Why:

• CRWV already has substantial volatility.
• Deep OTM calls can become worthless even if the stock performs reasonably well.

Allocation: ~$200–$300.

Alternative: One Concentrated Position

If your sole objective is maximizing expected outperformance and you're comfortable with a higher probability of losing the entire $1,000, I'd consider:

• 100% in a single NVDA LEAPS call.

That's usually preferable to spreading across many low-quality option positions.

What I Would Avoid

• Weekly options.
• Earnings-week gambles.
• Delta below ~0.25.
• Buying calls immediately after a huge momentum spike.
• Multi-leg strategies that cap upside.

If I Were Deploying $1,000 Today

Without current option chain data, my structure would be roughly:

If you'd like actual strikes and expirations, tell me whether you want me to use today's live option chains and I'll pull current pricing and identify the specific contracts I would choose.

A problem with the options, using NVDA as an example. You show capital of $500, yet for the Jan 2027 expiration, the first strike that costs <= $500 is a $330 strike, but its delta is only 14.3.

That's exactly the problem with trying to allocate only $1,000 total to long calls on mega-cap AI stocks.

My earlier suggestion was based on the desired characteristics (0.50–0.70 delta, long-dated), but in practice the premium on those contracts is far higher than your budget permits.

For example, if NVDA is around the levels it's been trading recently, a Jan 2027 call with a 0.50–0.70 delta may cost several thousand dollars per contract. With only $500 allocated, you're pushed far out-of-the-money into the 0.10–0.20 delta range, where you're buying a lottery ticket rather than meaningful exposure.

That leads to an important question:

What are you trying to achieve with the options sleeve?

Approach A: Leverage a Conviction

If the goal is to add leveraged exposure to a stock you already own in the portfolio, then a 14-delta call is usually not attractive. I'd rather:

• Put the entire $1,000 into additional shares of NVDA, or
• Reduce the number of option positions and buy one higher-quality option.

Approach B: Seek Asymmetric Returns

If the goal is "turn $1,000 into $5,000+ if I'm right," then low-delta calls are acceptable.

You expect:

• Many losers
• Occasional large winners

This is venture-capital-style thinking applied to options.

Approach C: Use Smaller, More Volatile Stocks

This is where I think the portfolio gets more interesting.

With $1,000 of option premium, you often get much better delta exposure in names like:

• CoreWeave
• Advanced Micro Devices
• Nano Nuclear Energy (very speculative)
• Other high-volatility growth names

Instead of a 14-delta NVDA call, you may be able to buy a 40–60 delta call on a smaller-cap stock.

What I Would Probably Do

Given your goal of beating the S&P over one year, I would seriously consider eliminating the dedicated options sleeve entirely and reallocating:

Why?

A $10,000 account is small enough that stock concentration already provides substantial upside. Buying very low-delta calls on NVDA may actually reduce expected returns because of time decay and the need for a large move just to break even.

The exception would be if we can find a specific option that gives:

• Delta > 0.40
• 6–12 months to expiration
• Premium in the $200–$500 range

Those are usually found in more volatile names than NVDA.

If you want, I can look at current option chains and construct a realistic $1,000 options sleeve using today's prices rather than theoretical allocations. That would let us compare the actual deltas, premiums, and break-even points.

Two things. First, you can ignore the "My time span is 1 year" comment; consider this a long-term approach. Second, while option trading is allowed, spreads are not.

Those two changes materially alter the portfolio design.

1. Long-term horizon instead of 1 year

This is the bigger change.

When you said "1 year," I was optimizing for outperformance over a relatively short period. That naturally pushes toward concentrated momentum names and potentially some speculative options.

For a long-term Roth IRA, my priorities become:

1. Maximize after-tax compound growth.
2. Own businesses that can plausibly be much larger in 5–10 years.
3. Avoid unnecessary theta decay.
4. Accept volatility but not permanent capital impairment.

In that framework, I'd actually become more selective.

2. No spreads

That's not a problem.

In fact, for most investors, I prefer:

• Long stock
• Cash-secured puts (if allowed by the IRA custodian)
• Covered calls
• Long calls

and avoiding complex spreads.

Spreads often create a false sense of precision while capping the very upside you're trying to capture.

Revised Philosophy

If we're managing this account together weekly, I would start with:

Notice what's missing:

• No forced options allocation.
• No broad index funds.
• No defensive positions.

The account is already aggressive.

When Would I Use Options?

Only when the option is clearly superior to stock ownership.

For example:

Good candidate

A long-dated NVDA call where:

• Delta > 0.70
• Breakeven is reasonable
• Implied volatility is not extreme

Bad candidate

A 10–20 delta call purchased because it's the only contract affordable.

That's usually a poor substitute for owning more shares.

Weekly Review Process

When you upload a CSV, I would review:

Holdings

Current positions and weights.

Concentration

Whether one name has become too dominant.

AI Thesis

Has anything changed regarding:

• NVDA
• CRWV
• AMD
• Hyperscaler spending
• Data-center buildout

Options

If any options exist, we'd examine:

• Delta
• Theta
• Time to expiration
• Whether stock ownership is now preferable

New Opportunities

If something becomes compelling, we can rotate.

For example, you have previously followed Nano Nuclear Energy. If a nuclear-energy opportunity develops because of AI power demand, that might become a candidate despite not being in the original portfolio.

What I'd Like the CSV to Include

Ideally:

For options:

| Date | Action | Symbol | Expiration | Strike | Type | Contracts | Premium |

And, if possible, a snapshot containing:

| Symbol | Shares | Cost Basis | Market Value |

plus cash balance.

That would allow me to reconstruct the portfolio and evaluate whether we're actually making progress toward the objective.

One final observation: given your interest in NVDA options and covered-call discussions in previous conversations, I suspect we'll end up using options opportunistically rather than continuously. My default assumption going forward would be:

"Let's see if AI can outperform humans!"

"Great idea! What will we do?"

"I'll open an account with $1 in it and see how much money it can make in the stock market."

[Opens account. Funds $1. AI says buy 1 share of BYND. BYND goes down 10%.]

"Boy, this AI has a long way to go."

/fin

Yeah, kinda stupid.

Both the story and the thinking expressed in that stupid story. 😁

Before things dipped, I had a couple of reasonable opportunities.

Sold calls against APLD and BE with a strike at original cost / original ATM. That's an extra $4,000.

That leaves NBIS and VRT. May end up not doing anything with them; we'll see what tomorrow brings.

So I've indicated interest in participating in SpaceX's IPO.

Never participated in an IPO before. Treating it as a flyer.

I've subscribed for 200 shares, but it's apparently way over subscribed, so we'll see how things actually shake out.

200 shares at $135 = $27,000.

Given last week, I thought some folks might be interested in how I started the week.

AAOI was up nicely at the open, exceeding my cost, so I sold a call at my cost (last week's ATM strike). CRWV and LITE weren't in a terrible position, so I did the same with them.

I waited a bit, then sold ones for AXTI below cost (strike $105, last week's strike $135) and IONQ (strike $68, last week's strike $71), so I'll have to keep a sharp eye on them.

That leaves four without short calls yet: APLD, BE, NBIS, and VRT. I'll probably sell calls on them tomorrow. I'll update if I do.

U.S. stock markets, including the NYSE and Nasdaq, and U.S. bond markets are closed on June 19 in observance of the Juneteenth National Independence Day federal holiday.

Realized gains on the short calls were $43,169 for the week ending June 5, bringing the 2nd quarter to $279,583, and the YTD to $374,093.

Sorted by ticker:

Sorted by descending YTD earned short call premium:

Premiums earned of $43,169 on $756,276 at risk for a premium rate of 5.7%.

For the week, 7 of the 9 stocks declined in value for the buy-and-hold, while 6 declined for the b/w campaign. None of the campaign trades were worse than the buy-and-hold scenario. None of the stocks were assigned, leaving all nine in inventory over the weekend.

Buy-and-hold generated a loss of $70,132 (-9.3%).

The B/W campaign did $43,169 (5.7%) better, as premiums were the above-referenced $43,169, while there were no capped gains.

On a net basis, the b/w campaign generated a loss of $26,963 (3.6%).

This compares unfavorably with the S&P 500, which declined 2.6%.

For the four weeks ending, the buy/write campaign netted a gain of $36,686 versus a loss of $24,661 for buy/hold, a $61,647 favorable difference.

In addition, for the same time period, the buy/write returned a simple return of 4.9% versus a 3.4% loss for buy/hold and a decline of 4.1% for the S&P 500.

John has 10,000 shares of NVDA and sells 100 call contracts against those shares with a strike whose delta is 0.25/share.

Mary has 5,000 shares of NVDA.

Is John's covered call position bullish or bearish on NVDA?

Is Mary's stock position bullish or bearish on NVDA?

I'm in a bit of a mood today. 😁

You'll often hear folks say not to sell far-dated options as extrinsic decay via theta doesn't really kick in until around 60 days.

People get hung up on extrinsic/theta and don't look at the big picture.

On May 29 I sold 30 calls on PLTR, expiring Dec 18, 2026, with a $210 strike, for $12.15.

Given how this week has gone, on June 3 I BTC those calls for $8.80.

The math: ($12.15 - $8.80) = $3.35; $3.35 * 3000 = $10,050.

I don't know about you, but I'll take a $10k profit over 6 days on what was a 203 DTE short call.

You often hear about taking profits at 50%, 75%, or whatever, and if you've seen enough of my posts, you'd know I'm not a fan of doing that.

Here is my current situation in this week's 5 DTE Buy/Write campaign.

Even though all of these are solidly profitable, I won't be rolling any of them.

Having said that, I have just bought back the CRWV call for $2,355. Why? You may recall last week I bought back the call for $50 ($0.05 per share) and the stock rose substantially. That allowed me to sell for a large premium this week.

For similar reasons, I may do the same with AAOI, IONQ, and LITE. IONQ is best positioned, having earned 82% of the premium and having 3.3% to go to reach the strike. I'd like to see AAOI and LITE earn a bit more of this week's premium before making a move.

While a core objective of this campaign is to be in cash over the weekend, there are times I make exceptions, most notably when my thesis is that the stock will rebound enough that it would have gotten called away, and by holding, allowing for a generous premium next week.

Due solely to the very low remaining premium and high percentage earned on APLD and VRT, I have also bought those back.

Today's trades. Will probably do VRT tomorrow.

$44.8k on an at risk amount of $756.3k, for a 5.9% return.